Click on headlines below to download research

Interim Phase II CLEPSIDRA results at ESMO
Oryzon Genomics | 30/09/2019

On 28 September 2019, Oryzon presented additional data from its Phase IIa CLEPSIDRA trial with iadademstat, a selective LSD1 inhibitor, at the ESMO congress…

Diversifying outside Argentina
Codere | 19/09/2019

Growth from Mexico and Spain, combined with ongoing operational efficiencies, continues to offset pressure from the Argentine division (23% of Q219 revenues).…

EUR25m debt financing to fund current strategy
ADL Bionatur Solutions | 14/08/2019

ADL Bionatur Solutions (ADL-BS) announced on 12 August 2019 that it has agreed to obtain €25m in debt financing with Kartesia, a private lender, at…

New contract to serve Asia-Pacific API market
ADL Bionatur Solutions | 08/08/2019

ADL Bionatur Solutions (ADL-BS) announced on 7 August 2019 that it entered into a strategic alliance with an undisclosed new customer in Japan to produce…

Outperforming the market
Laboratorios Farmaceuticos ROVI | 01/08/2019

Interim results highlight the momentum at Laboratorios Farmacéuticos ROVI, as both H119 operating revenue (21% y-o-y to €177.5m) and EBITDA…

Amyris contract extended to 2020
ADL Bionatur Solutions | 24/07/2019

ADL Bionatur Solutions (ADL-BS) announced on 22 July 2019 that its existing contract manufacturing (CMO) production agreement with Amyris (AMRS, Nasdaq)…

Interim data from Phase IIa ETHERAL AD study
Oryzon Genomics | 18/07/2019

On 15 July 2019, Oryzon presented interim data from the Phase IIa ETHERAL trial at the Alzheimer's Association International Conference (AAIC 2019)…

Restructured with new leadership
Codere | 18/07/2019

Codere is an established retail gaming operator in Latin America, Spain and Italy. Following macro and financial difficulties, it completed a successful…

Positive signals from first ALICE trial dataset
Oryzon Genomics | 18/06/2019

On 14 June 2019, Oryzon presented dose-finding data from the Phase II ALICE trial at the 24th Congress of the European Hematology Association (EHA-2019)…